Drug
Amivantamab-vmjw
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Infusion Related Reaction | 721 | 70.8 | 90.6 | signal |
| 2 | Adverse Reaction | 45 | 21.8 | 22.1 | signal |
| 3 | Cytopenia | 28 | 15.1 | 15.2 | signal |
| 4 | Mucosal Inflammation | 60 | 14.8 | 15.1 | signal |
| 5 | Skin Reaction | 30 | 13.7 | 13.8 | signal |
| 6 | Folliculitis | 21 | 13.1 | 13.1 | signal |
| 7 | Myelosuppression | 66 | 12.5 | 12.7 | signal |
| 8 | Skin Disorder | 63 | 12.2 | 12.4 | signal |
| 9 | Pneumonitis | 51 | 12.1 | 12.3 | signal |
| 10 | Scab | 21 | 11.9 | 12.0 | signal |
| 11 | Metastases To Central Nervous System | 21 | 10.5 | 10.6 | signal |
| 12 | Oxygen Saturation Decreased | 82 | 9.4 | 9.7 | signal |
| 13 | Tubulointerstitial Nephritis | 25 | 8.6 | 8.6 | signal |
| 14 | Hepatic Cytolysis | 16 | 8.4 | 8.4 | signal |
| 15 | Haematotoxicity | 12 | 8.3 | 8.3 | signal |
| 16 | Stomatitis | 76 | 8.0 | 8.2 | signal |
| 17 | Oesophagitis | 12 | 7.0 | 7.1 | signal |
| 18 | Rash | 475 | 7.0 | 8.1 | signal |
| 19 | Skin Haemorrhage | 15 | 6.7 | 6.7 | signal |
| 20 | Renal Tubular Necrosis | 10 | 6.5 | 6.5 | signal |
| 21 | Interstitial Lung Disease | 48 | 6.4 | 6.5 | signal |
| 22 | Status Epilepticus | 11 | 6.2 | 6.3 | signal |
| 23 | Hypocalcaemia | 18 | 6.1 | 6.2 | signal |
| 24 | Oedema | 45 | 5.3 | 5.4 | signal |
| 25 | Bronchospasm | 11 | 4.9 | 4.9 | signal |
| 26 | Flushing | 76 | 4.8 | 4.9 | signal |
| 27 | Pulmonary Embolism | 71 | 4.8 | 4.9 | signal |
| 28 | Skin Lesion | 20 | 4.7 | 4.7 | signal |
| 29 | Ulcer | 11 | 4.4 | 4.4 | signal |
| 30 | Skin Fissures | 13 | 4.4 | 4.4 | signal |
| 31 | Drug Intolerance | 65 | 4.3 | 4.4 | signal |
| 32 | Febrile Neutropenia | 44 | 4.3 | 4.3 | signal |
| 33 | Blood Pressure Decreased | 44 | 4.3 | 4.3 | signal |
| 34 | Shock | 15 | 4.2 | 4.2 | signal |
| 35 | Generalised Oedema | 8 | 4.2 | 4.2 | signal |
| 36 | Anaphylactic Reaction | 35 | 4.1 | 4.1 | signal |
| 37 | Pneumothorax | 10 | 4.0 | 4.1 | signal |
| 38 | Pancytopenia | 35 | 4.0 | 4.1 | signal |
| 39 | Anaphylactic Shock | 16 | 4.0 | 4.0 | signal |
| 40 | Adverse Event | 57 | 4.0 | 4.0 | signal |
| 41 | Adverse Drug Reaction | 52 | 3.7 | 3.8 | signal |
| 42 | Cholestasis | 11 | 3.7 | 3.7 | signal |
| 43 | Mouth Ulceration | 12 | 3.7 | 3.7 | signal |
| 44 | Chest Discomfort | 58 | 3.7 | 3.7 | signal |
| 45 | Skin Ulcer | 14 | 3.5 | 3.5 | signal |
| 46 | Bone Marrow Failure | 11 | 3.5 | 3.5 | signal |
| 47 | Intestinal Perforation | 6 | 3.4 | 3.4 | signal |
| 48 | Deep Vein Thrombosis | 34 | 3.3 | 3.4 | signal |
| 49 | Hepatic Function Abnormal | 19 | 3.3 | 3.3 | signal |
| 50 | Toxic Skin Eruption | 5 | 3.2 | 3.2 | signal |
| 51 | Inappropriate Antidiuretic Hormone Secretion | 5 | 3.2 | 3.2 | signal |
| 52 | Metastases To Bone | 8 | 3.1 | 3.1 | signal |
| 53 | Agranulocytosis | 9 | 3.1 | 3.1 | signal |
| 54 | Thrombocytopenia | 50 | 2.9 | 2.9 | signal |
| 55 | Retinal Detachment | 4 | 2.8 | 2.8 | no signal |
| 56 | Neutrophil Count Decreased | 17 | 2.7 | 2.7 | signal |
| 57 | Hospice Care | 4 | 2.6 | 2.6 | no signal |
| 58 | Neutropenia | 55 | 2.6 | 2.6 | signal |
| 59 | Secretion Discharge | 5 | 2.6 | 2.6 | no signal |
| 60 | Full Blood Count Abnormal | 4 | 2.4 | 2.4 | no signal |
| 61 | Acne | 28 | 2.4 | 2.4 | signal |
| 62 | Cytokine Release Syndrome | 7 | 2.4 | 2.4 | signal |
| 63 | Peritonitis | 6 | 1.9 | 1.9 | no signal |
| 64 | Central Nervous System Lesion | 4 | 1.9 | 1.9 | no signal |
| 65 | Ischaemic Stroke | 5 | 1.8 | 1.8 | no signal |
| 66 | Pulmonary Thrombosis | 3 | 1.8 | 1.8 | no signal |
| 67 | Nephropathy Toxic | 3 | 1.7 | 1.7 | no signal |
| 68 | Myocarditis | 3 | 1.7 | 1.7 | no signal |
| 69 | Dry Skin | 32 | 1.6 | 1.6 | no signal |
| 70 | Skin Irritation | 8 | 1.1 | 1.1 | no signal |